Saltar al contenido

What an exome includes (and what it does not)

Exome testing is the most requested test in medical genetics and also the one that generates the most false expectations. What it really includes, what is left out, and how much each piece costs.

What an exome is

The exome is the protein-coding regions of DNA: a little over 20,000 genes, around 1-2% of the genome. That is where most of the variants that cause inherited disease are found, and that is why it is looked at first when a genetic disease is suspected.

What the analysis includes

  • Sequencing of exonic regions with sufficient depth (100x or more).
  • Alignment, variant calling (SNV and indels) and annotation against frequency and pathogenicity databases.
  • Variant classification under ACMG/AMP criteria.
  • Filtering by genes associated with the clinical suspicion or by phenotype.
  • Technical report with the variants found and the evidence for each one.

What is left out

This is what almost nobody explains before you order it.

  • Non-coding regions. The exome does not look at the remaining 98% of the genome. There are diseases caused by regulatory variants that an exome does not see.
  • Large rearrangements and repeat expansions. They are seen only partially, and often not at all.
  • Methylation. That is a different technique.
  • Low-level mosaicism. Below a certain proportion of affected cells, the technique cannot tell it apart.
  • A diagnosis. A significant share of cases stays without a genetic explanation, even with a well-done, well-interpreted exome. The report gives you variants and their evidence; the clinical conclusion is made by the physician.

Where the real work is

Sequencing has become much cheaper. What costs expert hours is the interpretation: reviewing the candidate variants, checking the evidence for each one, discarding the ones that do not fit and writing down the reason why. That work is human and cannot be fully automated.

That is why it pays to separate the pieces when you compare quotes: sequencing, bioinformatics analysis and interpretation are not the same thing.

Our prices, itemised

  • Exome sequencing (WES 100x): from 300 €/sample
  • Variant analysis and annotation: 40 €/sample
  • WES interpretation (trio): 119 €/case
  • CNV and structural variants: 54 €/sample each
  • Reanalysis when references change: 60 €/case
  • Minimum project fee 150 €

We work as a technical report, for professional use and research. We do not issue a signed clinical report: that falls to a laboratory accredited in ISO 15189, and we are not one.

Before you order it

  • Ask for the price of each piece, not just the total.
  • Ask what happens if nothing is found: the report is delivered anyway, with whatever there is.
  • If there are more cases in the family, the trio (parents and affected individual) greatly increases filtering power.

If you like, calculate the budget with the calculator or tell us about your case and we will tell you which design makes sense.

Calculate my budget → Discuss my case

Who writes this

Bioinformatics team at OmicaLabs. We have run our own laboratory since 1978 (ISO 9001:2015, ES147645-1), analysing sequencing data for research and clinical use. We publish our prices and the validation of our pipelines.

OmicaLabs